Goldman Sachs’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-29,807
| Closed | -$451K | – | 5112 |
|
|
2024
Q2 | $451K | Buy |
29,807
+15,336
| +106% | +$232K | ﹤0.01% | 4011 |
|
|
2024
Q1 | $214K | Sell |
14,471
-20,726
| -59% | -$306K | ﹤0.01% | 4308 |
|
|
2023
Q4 | $472K | Buy |
35,197
+244
| +0.7% | +$3.27K | ﹤0.01% | 3975 |
|
|
2023
Q3 | $431K | Buy |
34,953
+20,811
| +147% | +$257K | ﹤0.01% | 3940 |
|
|
2023
Q2 | $174K | Sell |
14,142
-20,756
| -59% | -$255K | ﹤0.01% | 4440 |
|
|
2023
Q1 | $429K | Buy |
34,898
+20,756
| +147% | +$255K | ﹤0.01% | 4156 |
|
|
2022
Q4 | $162K | Buy |
+14,142
| New | +$162K | ﹤0.01% | 4566 |
|
|
2022
Q3 | – | Sell |
-14,142
| Closed | -$84K | – | 5959 |
|
|
2022
Q2 | $84K | Buy |
+14,142
| New | +$84K | ﹤0.01% | 5168 |
|
|
2019
Q2 | – | Sell |
-33,572
| Closed | -$184K | – | 4416 |
|
|
2019
Q1 | $184K | Sell |
33,572
-103
| -0.3% | -$565 | ﹤0.01% | 3913 |
|
|
2018
Q4 | $102K | Sell |
33,675
-58,706
| -64% | -$178K | ﹤0.01% | 3884 |
|
|
2018
Q3 | $387K | Sell |
92,381
-80,781
| -47% | -$338K | ﹤0.01% | 3553 |
|
|
2018
Q2 | $669K | Buy |
173,162
+136,499
| +372% | +$527K | ﹤0.01% | 3395 |
|
|
2018
Q1 | $232K | Sell |
36,663
-12,497
| -25% | -$79.1K | ﹤0.01% | 3794 |
|
|
2017
Q4 | $396K | Sell |
49,160
-89,411
| -65% | -$720K | ﹤0.01% | 3550 |
|
|
2017
Q3 | $1.59M | Buy |
138,571
+22,810
| +20% | +$261K | ﹤0.01% | 2985 |
|
|
2017
Q2 | $1.13M | Sell |
115,761
-44,980
| -28% | -$439K | ﹤0.01% | 3094 |
|
|
2017
Q1 | $3.9M | Buy |
160,741
+140,197
| +682% | +$3.4M | ﹤0.01% | 2340 |
|
|
2016
Q4 | $660K | Buy |
20,544
+5,292
| +35% | +$170K | ﹤0.01% | 3301 |
|
|
2016
Q3 | $762K | Buy |
15,252
+1,221
| +9% | +$61K | ﹤0.01% | 3196 |
|
|
2016
Q2 | $595K | Buy |
14,031
+6,445
| +85% | +$273K | ﹤0.01% | 3221 |
|
|
2016
Q1 | $499K | Buy |
7,586
+3,911
| +106% | +$257K | ﹤0.01% | 3222 |
|
|
2015
Q4 | $229K | Sell |
3,675
-20,051
| -85% | -$1.25M | ﹤0.01% | 3660 |
|
|
2015
Q3 | $1.59M | Sell |
23,726
-10,208
| -30% | -$684K | ﹤0.01% | 2668 |
|
|
2015
Q2 | $3.3M | Sell |
33,934
-2,215
| -6% | -$215K | ﹤0.01% | 2303 |
|
|
2015
Q1 | $3.38M | Sell |
36,149
-3,004
| -8% | -$281K | ﹤0.01% | 2244 |
|
|
2014
Q4 | $3.48M | Sell |
39,153
-224
| -0.6% | -$19.9K | ﹤0.01% | 2187 |
|
|
2014
Q3 | $2.72M | Sell |
39,377
-44,278
| -53% | -$3.06M | ﹤0.01% | 2332 |
|
|
2014
Q2 | $4.8M | Buy |
83,655
+58,448
| +232% | +$3.35M | ﹤0.01% | 2036 |
|
|
2014
Q1 | $1M | Buy |
25,207
+3,278
| +15% | +$130K | ﹤0.01% | 2988 |
|
|
2013
Q4 | $920K | Buy |
21,929
+1,310
| +6% | +$55K | ﹤0.01% | 3110 |
|
|
2013
Q3 | $615K | Buy |
20,619
+1,019
| +5% | +$30.4K | ﹤0.01% | 3217 |
|
|
2013
Q2 | $1.04M | Buy |
+19,600
| New | +$1.04M | ﹤0.01% | 2785 |
|